Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advancing Medical Innovation (AMI) is a Boston-based medical technology company and incubator dedicated to fostering the development of innovative medical products through strategic partnerships. The company focuses on establishing proof of concept and demonstrating clinical value for young technologies, often facilitating their path to market through licensing or the formation of specialized subsidiaries. A notable achievement of AMI is the formation of Sidoris Biomedical, which focuses on commercializing medical devices utilizing proprietary bioresorbable metal technology. This next-generation material is designed to provide structural support for a required clinical duration before safely dissolving, addressing needs in surgical stapling, mesh fixation, and ligation. AMI plays an active role in bridging the gap between start-up innovation and industry-leading manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advancing Medical Innovation.